Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05588388
Title Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases (BELIEVE)
Acronym BELIEVE
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kamya Sankar
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries USA

Facility Status City State Zip Country Details
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles California 90048 United States Details
V.A. Ann Arbor Healthcare System Ann Arbor Michigan 48105 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field